Your prediction
Protalix Biotherapeutics Inc. Stock
Heavy losses for Protalix Biotherapeutics Inc. today as the stock fell by -€0.080 (-4.260%).
Our community identified positive and negative aspects for Protalix Biotherapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Protalix Biotherapeutics Inc. stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Protalix Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Protalix Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | -4.260% | -6.160% | -1.189% | -30.229% | 19.477% | -15.095% | -64.505% |
| Compugen Ltd. | 8.000% | 9.917% | 45.833% | 128.522% | 102.128% | 383.636% | - |
| Chromadex Corp | -0.500% | -2.439% | 4.167% | -37.500% | -27.273% | 222.581% | -37.984% |
| Intellia Therapeutics Inc | -14.260% | -8.346% | 4.582% | 62.072% | 49.116% | -64.802% | -82.020% |
